• Weis Markets posted Q2 net income of USD 22.86 million, down 9.6% year over year; EPS slipped to USD 0.92.
• Total revenue rose 4.6% to USD 1.28 billion; comparable store sales increased 2.3% year over year.
• Pharmacy revenue growth was hit by about USD 10.71 million from Inflation Reduction Act Medicare maximum fair price provisions effective Jan. 1, 2026.
• Year-to-date net income climbed 13.1% to USD 50.71 million; total revenue increased 4.6% to USD 2.53 billion.
• Management cited higher promotional and targeted loyalty-marketing investment, while maintaining strong in-stock levels and a consistent shopping experience.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Weis Markets Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608041700PR_NEWS_USPR_____NE19354) on August 04, 2026, and is solely responsible for the information contained therein.